Concepedia

Steve Pawsey

SP

4

Publications

181

Citations

4

H-Index

2020

Active since

Affiliations

NeRRe Therapeutics (United Kingdom)(Current)

University of Edinburgh

Brigham and Women's Hospital

Queen's Medical Centre

George Washington University

Steve Pawsey is an author at NeRRe Therapeutics (United Kingdom) specializing in obstetrics, public health, and menopause.

Top concepts

Publications per year

2020–2023

4

Publications

4

Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial

Mike Trower, Richard A. Anderson, Elizabeth Ballantyne et al. · Menopause The Journal of The North American Menopause Society · 2020 · 71 citations · Full text

Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)

James A. Simon, Richard A. Anderson, Elizabeth Ballantyne et al. · Menopause The Journal of The North American Menopause Society · 2023 · 68 citations · Full text

Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women

Steve Pawsey, Edouard Gregory Mills, Elizabeth Ballantyne et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 29 citations · Full text

OR11-03 NT-814, a Non-Hormonal Dual Neurokinin 1,3 Receptor Antagonist Markedly Improves Vasomotor Symptoms in Post-Menopausal Women; Results of a Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Study (SWITCH-1)

James A. Simon, Richard A. Anderson, Elizabeth Ballantyne et al. · Journal of the Endocrine Society · 2020 · 13 citations · Full text

, , +27

Rows per page

1–4 of 4